Tuberculosis Screening by Tuberculosis Skin Test or QuantiFERON？-TB Gold In-Tube Assay among an Immigrant Population with a High Prevalence of Tuberculosis and BCG Vaccination
Rationale Each year 1 million persons acquire permanent U.S. residency visas after tuberculosis (TB) screening. Most applicants undergo a 2-stage screening with tuberculin skin test (TST) followed by CXR only if TST-positive at > 5 mm. Due to cross reaction with bacillus Calmette-Guérin (BCG), TST may yield false positive results in BCG-vaccinated persons. Interferon gamma release assays exclude antigens found in BCG. In Vietnam, like most high TB-prevalence countries, there is universal BCG vaccination at birth. Objectives 1. Compare the sensitivity of QuantiFERON ？-TB Gold In-Tube Assay (QFT) and TST for culture-positive pulmonary TB. 2. Compare the age-specific and overall prevalence of positive TST and QFT among applicants with normal and abnormal CXR. Methods We obtained TST and QFT results on 996 applicants with abnormal CXR, of whom 132 had TB, and 479 with normal CXR. Results The sensitivity for tuberculosis was 86.4% for QFT; 89.4%, 81.1%, and 52.3% for TST at 5, 10, and 15 mm. The estimated prevalence of positive results at age 15–19 years was 22% and 42% for QFT and TST at 10 mm, respectively. The prevalence increased thereafter by 0.7% year of age for TST and 2.1% for QFT, the latter being more consistent with the increase in TB among applicants. Conclusions During 2-stage screening, QFT is as sensitive as TST in detecting TB with fewer requiring CXR and being diagnosed with LTBI. These data support the use of QFT over TST in this population.？
References
[1]
Centers for Disease Control and Prevention (2011) Trends in tuberculosis--United States, 2010. MMWR Morb Mortal Wkly Rep 60: 333-337. PubMed: 21430636.
[2]
Monger RY, James (2012) U.S. Legal Permanent Residents: 2011. In: Annual Flow Report. Department of Homeland Security, editor.
[3]
Monger R (2012) Nonimmigrant Admissions to the United States: 2011. In: Annual Flow Report. Department of Homeland Security.
[4]
Liu Y, Painter JA, Posey DL, Cain KP, Weinberg MS et al. (2012) Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States. PLOS ONE 7: e32158. doi:10.1371/journal.pone.0032158. PubMed: 22384165.
[5]
Cain KP HC, Armstrong LR, Garman KN, Wells CD, Iademarco CF, Castro KG, Laserson KF (2007) Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination Am J Respir Crit Care Med 175: 75-79. doi:10.1164/rccm.200608-1178OC. PubMed: 17038659.
[6]
Hill AN, Becerra JE, Castro KG (2012) Modelling tuberculosis trends in the USA. Epidemiol Infect, 140: 1-11. PubMed: 22233605.
[7]
Reves RR, Nolan CM (2012) Tuberculosis elimination in the United States: an achievable goal or an illusion? Am J Respir Crit Care Med 186: i-iii. doi:10.1164/rccm.201206-1039ED. PubMed: 22855550.
[8]
Centers for Disease Control and Prevention (2007) CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment. (Accessed November 25, 2013 at .).
[9]
Centers for Disease Control and Prevention (2009) CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy In: Technical Instructions for Medical Examination of Aliens; (Accessed Nov 25 (2013). Available http://www.cdc.gov/immigrantrefugeehealt？h/pdf/tuberculosis-ti-2009.pdf.
[10]
Centers for Disease Control and Prevention (2008) Tuberculosis Component Of Technical Instructions For The Medical Examination Of Aliens In The United States. In: Technical Instructions for Medical Examination of Aliens; (Accessed May 25 (2012). Available http://www.cdc.gov/immigrantrefugeehealt？h/pdf/tb-ti-civil.pdf.
[11]
American College Health A (2011) Tuberculosis screening and targeted testing of college and university students. J Am Coll Health 59: 670-677.
[12]
Centers for Disease Control and Prevention (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49: 1-51.
[13]
Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S et al. (2010) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 59: 1-25. PubMed: 20577159.
[14]
Blum RN, Polish LB, Tapy JM, Catlin BJ, Cohn DL (1993) Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status. Chest 103: 1670-1674. doi:10.1378/chest.103.6.1670. PubMed: 8404083.
[15]
Stout JE (2008) Predicting Tuberculosis: Does the IGRA Tell the Tale? Am J Respir Crit Care Med 177: 1055-1057. PubMed: 18460459.
[16]
Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M (2008) Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis 12: 498-505. PubMed: 18419884.
[17]
Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204. PubMed: 17131776.
[18]
Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK et al. (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520-1523. doi:10.1126/science.284.5419.1520. PubMed: 10348738.
[19]
van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P (2000) Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 7: 155-160. PubMed: 10702486.
[20]
Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D et al. (2011) The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 8: e1001012. PubMed: 21445325.
[21]
World Health Organization (2010) Global Tuberculosis Control 2011. Geneva: World Health Organization.
[22]
Maloney SA, Fielding KL, Laserson KF, Jones W, Nguyen TN et al. (2006) Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam. Arch Intern Med 166: 234-240. doi:10.1001/archinte.166.2.234. PubMed: 16432095.
[23]
Kent PT GK, (1985) Public Health Mycobacteriology: a Guide for the Level III Laboratory. Atlanta, GA.: U.S. Department of Health and Human Services, Centers for Disease Control.
[24]
Murray PR, editor (1999) Manual of Clinical Microbiology 7th edition. Washington DC: ASM Press. 409 pp.
[25]
Somosk？vi A, K？dm？n C, Lantos A, Bártfai Z, Tamási L et al. (2000) Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium. J Clin Microbiol 38: 2395-2397. PubMed: 10835013.
[26]
Reisner BS, Gatson AM, Woods GL (1994) Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures. J Clin Microbiol 32: 2995-2998. PubMed: 7883888.
[27]
Team RDC (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing.
[28]
Wickaham H (2009) ggplot2: Elegant Graphics for Data Analysis. New York: Springer.
[29]
Lumley T (2004) Anaysis of complex survey samples. Journal of Statistical Software 9: 1-99.
[30]
Czajkowski M, Gill R, Rempala G (2008) Model selection in logistic joinpoint regression with applications to analyzing cohort mortality patterns. Stat Med 27: 1508-1526. doi:10.1002/sim.3017. PubMed: 17676590.
[31]
Jacobs S, Warman A, Richardson R, Yacoub W, Lau A et al. (2011) The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection. Pediatr Infect Dis J 30: 754-758. doi:10.1097/INF.0b013e31821b8f54. PubMed: 21487326.
[32]
Winje BA, Oftung F, Korsvold GE, Manns？ker T, Ly IN et al. (2008) School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. BMC Infect Dis 8: 140. doi:10.1186/1471-2334-8-140. PubMed: 18928541.
[33]
Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354. doi:10.7326/0003-4819-146-5-200703060-00006. PubMed: 17339619.
[34]
Dai Y, Feng Y, Xu R, Xu W, Lu W et al. (2012) Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 31: 3127-3137. doi:10.1007/s10096-012-1674-y. PubMed: 22833244.
[35]
Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D et al. (2011) Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37: 88-99. doi:10.1183/09031936.00115110. PubMed: 21030451.
[36]
Diel R, Loddenkemper R, Nienhaus A (2010) Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137: 952-968. doi:10.1378/chest.09-2350. PubMed: 20022968.
[37]
Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184. doi:10.7326/0003-4819-149-3-200808050-00241. PubMed: 18593687.
[38]
Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW et al. (2010) National survey of tuberculosis prevalence in Viet Nam. Bull World Health Organ 88: 273-280. doi:10.2471/BLT.09.067801. PubMed: 20431791.
